Introduction Children with recurrent urinary tract infections (rUTI) often show no identifiable cause of their infections. Neutrophil gelatinase-associated lipocalin (NGAL) is known to be upregulated within the uroepithelium and kidney of patients with UTI and exhibits a localized bacteriostatic effect through iron chelation. We hypothesize that some patients with rUTI without an identifiable cause of their recurrent infections have locally deficient NGAL production. We therefore explored whether a lack of NGAL production may be a factor in the pathogenesis of rUTI. Materials and methods Patients seen in the urology clinic for rUTI who were <21 years of age were enrolled. Patients were excluded if they had UTI at the time of enrollment, evidence of renal disease, decreased renal function, known anatomic abnormality of the genitourinary tract, or other reasons that predispose to UTI, such as neurogenic bladder, the need for intermittent catheterization, or unrepaired posterior urethral valves. Control patients were healthy children enrolled from the emergency department with no history of UTI or renal dysfunction, normal urinalysis at the time of enrollment, and presenting no diagnosis associated with increased NGAL levels, such as acute kidney injury or infection. NGAL was measured by immunoblot. Results Fifteen cases and controls were enrolled. Median urinary NGAL levels were significantly decreased in rUTI patients compared with controls [15 (14-29) ng/ml vs 30 (27-61) ng/ml; p = 0.002)] Although comparatively diminished, measurable NGAL levels were present in all patients with rUTI. Conclusions Urinary NGAL is significantly decreased in patients with compared with patients without rUTI. These data suggest that some patients with rUTI may be predisposed to UTI because of a relative local deficiency in urinary NGAL production.
Introduction
Urinary tract infections (UTI) are common within the pediatric population. Recurrent UTIs (rUTI) occur in ∼12% of patients following an initial UTI [1] . The pathophysiology of rUTI is multifactorial but is not fully understood. Deficiencies in the innate immune system are likely involved.
Neutrophil gelatinase-associated lipocalin (NGAL), a protein expressed in the uroepithelium [2] , functions within the innate immune system by exerting a bacteriostatic effect on gram-negative bacteria through iron chelation [3] . Urinary NGAL (uNGAL) is variably upregulated in UTI [4] . Given the role of NGAL in bacteriostasis and its upregulation in UTI, we sought to determine whether a subset of patients with rUTI were deficient in uNGAL.
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Methods
This study was approved by the Boston Children's Hospital Institutional Review Board, and informed consent was obtained. Patients were between the ages of 6 months and 21 years, had a history of rUTI, and were prospectively identified from the Department of Urology at Boston Children's Hospital from February 2013 through August 2013. rUTI was defined by two or more culture-proven UTIs with at least 100,000 cfu/ ml of a single uropathogen. Cases were excluded if there was suspicion of an active UTI as evidenced by either clinical symptoms, presence of leukocyte esterase or nitrites in urinalysis or any bacterial growth (>10,000 cfu/ml) in urine cultures, or if they had renal dysfunction or had a UTI within 30 days prior to enrollment. Eighteen patients were initially enrolled; three were excluded due to positive urine cultures at the time of enrollment.
Control patients were a convenience sample enrolled from the Emergency Department at Boston Children's Hospital. Patients who provided urine samples for routine clinical purposes were approached for inclusion in this study as controls. None of the control patients required fluid resuscitation or hospital admission or had any clinical parameters to suggest dehydration, such as tachycardia or decreased urine output. Controls were excluded if they had a history of a UTI, evidence of a UTI at the time of enrollment (defined above), known or suspected renal dysfunction, or any urologic history. To enroll otherwise healthy children as controls, patients followed by any subspecialists were not included as controls. This was determined through a combination of parental reports and chart review. Fifteen patients were enrolled as controls, of whom 53% had a urine sample sent for a pregnancy test prior to radiologic imaging for an orthopedic injury, 33% presented with constipation with relief of symptoms following enema, and 13% presented with headache.
Samples were centrifuged at 12,000 RPM for 5 min, aliquoted, and stored at −80°C within 12 h of collection. uNGAL measurements were performed in duplicate by Western blot with 10-μl samples. Nonreducing 4-20% gradient polyacrylamide gels (Bio-Rad, Hercules, CA, USA) were used for electrophoresis. uNGAL was detected with monoclonal antibodies to NGAL (1:1000, Antibody Shop, BioPorta Diagnostics, Gentofte, Denmark) and with rabbit polyclonal secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA). Standards of human recombinant NGAL were used to standardize quantification [3] .
Patient data was collected from the electronic medical record. Data analysis was performed using SPSS 16.0 (SPSS, Chicago, IL, USA). We compared normally distributed continuous variables using a two-tailed Student's t test and categorical data by using chi-square tests, rejecting the null hypothesis at a significance of 0.05. Nonnormally distributed variables, i.e., uNGAL, were compared using the Mann-Whitney U test.
Results
There were 15 patients in each group. There were more females in the rUTI group compared with the control group [100% vs. 87% (13) (14) (15) ; p < 0.01]. Patients in the control group were older than those with rUTI (13.6 ± 5.0 vs. 8.0 ± 3.9 years; p = 0.02) ( Table 1 ). All patients in the rUTI group underwent some type of radiologic imaging (Table 1) . Renal ultrasounds were normal in 87% (13/15), with the remaining identifying minimal and clinically nonrelevant pelviectasis. One patient had grade II vesicoureteral reflux, and both dimercaptosuccinate (DMSA) studies identified cortical defects. Median uNGAL levels were significantly lower in the rUTI patient cohort (15 (14,29) ng/ml vs 30 (27,61) ng/ml; p = 0.002).
Discussion
We demonstrate that patients with rUTI have significantly lower baseline uNGAL levels compared with healthy controls. The pathogenesis of rUTI is complex and heterogeneous. Various authors investigated the genetic basis of rUTI and identified several genes within the innate immune system that play a role in recurrent infection [5, 6] . Reduced toll-like receptor 4 (TLR4) expression has been suggested to promote an asymptomatic bacteriurial state [7] . TLR-4 is activated by lipopolysaccharides, which is found on the outer membrane of gram-negative bacteria, and induces NGAL expression in the alpha-intercalated cell [8] . This activation is essential in the innate immune response by activation of proinflammatory pathways and induction of cytokine expression.
NGAL exerts a bacteriostatic effect in the urinary tract by chelating iron from gram-negative bacteria. NGAL deficiency would potentially promote bacterial growth, increasing the [4, 9] . These studies were cross-sectional and measured NGAL levels during active infection. In contrast, our cohorts were measured during a period of quiescence, and the lower baseline level may be indicative of the increased risk for recurrence. The decision to not standardize uNGAL with urine creatinine is based on NGAL biology. Although standardization with urine creatinine is a common practice within the NGAL literature, we believe this is an imperfect standardization. NGAL is primarily produced within the collecting ducts and is essentially independent from glomerular filtration, whereas urine creatinine comes from the filtrate at the level of the glomerulus and represents a distinct biology from that of urine NGAL. Despite the relatively small size of NGAL, prior work demonstrates that serum NGAL is not filtered by the glomerulus. Indeed, even when large amounts of NGAL are injected into healthy mice, almost none is subsequently found in the urine. This is likely because NGAL is absorbed by megalin, a protein in the serum. When large amounts of NGAL are injected into a megalin knock-out mouse, significantly increased NGAL levels are found within the urine [10] .
Thirty-three percent of patients included as controls within our cohort who were diagnosed with constipation during their visit to the Emergency Department. While the association between dysfunctional elimination syndrome (DES) and UTIs in children is well documented, DES is common and is not a causative factor in UTIs [11] . Indeed, the rate of DES is similar between young children with and without a history of UTI [12] . Further, prevalence of UTI was no higher in children with than without constipation [13] . Finally, within a cohort of children with constipation, lack of UTI development suggests the presence of a normally functioning innate immune system, which is the reason for the control group in this study.
Although our findings of decreased uNGAL in patients with rUTI is intriguing, this pilot study has limitations, including small cohorts, cohort composition, its single-center design, and age difference between cases and controls. As in all comparative studies, obtaining optimal age-and sex-matched controls is challenging. A cohort of 368 healthy children showed that NGAL levels are significantly elevated in those aged 10-14 years, compared with children aged 5-9 years. In our study, mean age was 13.6 years in the control group and 8 years in the rUTI group [14] . However, while statistically significant, these differences are small (7.6 ng/ ml vs 4.5 ng/ml), and likely not a significant contribution. Conversely, the same study shows that females, who make up 100% of our rUTI group and 86.7% of our control group, have a significantly higher level of NGAL compared with males, 13.5 ng/ml versus 3.5 ng/ml. Therefore, while there are differences in NGAL levels based on age and gender, they are minimal and not likely to significantly affect our results.
Overall, we demonstrated an association between rUTI and a decreased level of uNGAL during an asymptomatic period. Although mechanistically appealing, no causality can be inferred from this data. It is possible that the decreased NGAL levels are secondary to renal scarring as a result of rUTI and that therefore the decreased NGAL levels are a result of rUTI. However, NGAL levels are increased in patients with renal scarring compared with those without, suggesting that renal scarring may not be a cause of decreased NGAL levels [15] . Confirmation of these results in a larger prospective cohort, with well-matched controls, will help further elucidate the relationship between NGAL levels and rUTI.
Conclusion
Baseline uNGAL levels during a clinically asymptomatic period were significantly lower in pediatric patients with rUTI compared with healthy controls. Lower uNGAL may either be the cause or the effect of rUTI.
